Generic placeholder image

Current Pediatric Reviews

Editor-in-Chief

ISSN (Print): 1573-3963
ISSN (Online): 1875-6336

General Review Article

Allergic Contact Dermatitis in Pediatric Practice

Author(s): Kam Lun Hon*, Alexander K.C. Leung, James W.C.H. Cheng, David C.K. Luk, Agnes S.Y. Leung and Mark J.A. Koh

Volume 20, Issue 4, 2024

Published on: 17 July, 2023

Page: [478 - 488] Pages: 11

DOI: 10.2174/1573396320666230626122135

Price: $65

conference banner
Abstract

Background: Allergic contact dermatitis (ACD) is prevalent among pediatric population, adolescent and young adults. Patients with ACD experience a lot of sociopsychological and qualityof- life (QoL) difficulties. Children and their caregivers alike are vulnerable to the burden of ACD.

Objectives: We have, in this paper, provided an overview of ACD and discussed common and unusual causes of ACD.

Methods: We performed an up-to-date literature review in the English language on “allergic contact dermatitis” via PubMed Clinical Queries, using the keywords “allergic contact dermatitis” in August 2022. The search included meta-analyses, randomized controlled trials, clinical trials, casecontrol studies, cohort studies, observational studies, clinical guidelines, case series, case reports, and reviews. The search was restricted to English literature and children.

Results: ACD may be acute or chronic and it affects more than 20% of children and adults with significant quality-of-life impairments. ACD is manifested by varying degrees of cutaneous edema, vesiculation, and erythema. The hypersensitivity reaction is one of the most prevalent forms of immunotoxicity in humans. Localized acute ACD lesions can be managed with high-potency topical steroids; if ACD is severe or extensive, systemic corticosteroid therapy is often required to provide relief within 24 hours. In patients with more severe dermatitis, oral prednisone should be tapered over 2-3 weeks. Rapid discontinuation of corticosteroids can result in rebound dermatitis. Patch testing should be performed if treatment fails and the specific allergen or diagnosis remains unknown.

Conclusion: ACD is common and can be a physically, psychologically, and economically burdensome disease. Diagnosis of ACD is primarily based on history (exposure to an allergen) and physical examination (morphology and location of the eruption). Skin patch test can help determine the causative allergen. Allergen avoidance is the cornerstone of management. Topical mid- or highpotency corticosteroids are the mainstay of treatment for lesions on less than 20% of the body area. Severe cases of ACD may require treatment with systemic corticosteroids.

Keywords: Allergen, allergic contact dermatitis, type IV delayed hypersensitivity, life quality, patch test, burdensome disease.

[1]
American Academy of Allergy, Asthma, and Immunology. Skin Allergy Symptoms, Diagnosis, Treatment & Management. 2020. Available From: https://www.aaaai.org/conditions-and-treatments/allergies/skin-allergy
[2]
Leung AKC, Hon KLE, Robson WLM. Atopic Dermatitis. Adv Pediatr 2007; 54(1): 241-73.
[http://dx.doi.org/10.1016/j.yapd.2007.03.013] [PMID: 17918474]
[3]
Antia C, Baquerizo K, Korman A, Alikhan A, Bernstein JA. Urticaria: A comprehensive review. J Am Acad Dermatol 2018; 79(4): 617-33.
[http://dx.doi.org/10.1016/j.jaad.2018.01.023] [PMID: 30241624]
[4]
Hon KL, Leung AKC, Ng WGG, Loo SK. Chronic urticaria: An overview of treatment and recent patents. Recent Pat Inflamm Allergy Drug Discov 2019; 13(1): 27-37.
[http://dx.doi.org/10.2174/1872213X13666190328164931] [PMID: 30924425]
[5]
Grob JJ, Gaudy-Marqueste C. Urticaria and quality of life. Clin Rev Allergy Immunol 2006; 30(1): 047-52.
[http://dx.doi.org/10.1385/CRIAI:30:1:047] [PMID: 16461995]
[6]
Kimber I, Basketter DA, Gerberick GF, Dearman RJ. Allergic contact dermatitis. Int Immunopharmacol 2002; 2(2-3): 201-11.
[http://dx.doi.org/10.1016/S1567-5769(01)00173-4] [PMID: 11811925]
[7]
Nassau S, Fonacier L. Allergic contact dermatitis. Med Clin North Am 2020; 104(1): 61-76.
[http://dx.doi.org/10.1016/j.mcna.2019.08.012] [PMID: 31757238]
[8]
Bains SN, Nash P, Fonacier L. Irritant contact dermatitis. Clin Rev Allergy Immunol 2019; 56(1): 99-109.
[http://dx.doi.org/10.1007/s12016-018-8713-0] [PMID: 30293200]
[9]
Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF. Allergic and irritant contact dermatitis. Eur J Dermatol 2009; 19(4): 325-32.
[http://dx.doi.org/10.1684/ejd.2009.0686] [PMID: 19447733]
[10]
Li Y, Li L. Contact dermatitis: Classifications and management. Clin Rev Allergy Immunol 2021; 61(3): 245-81.
[http://dx.doi.org/10.1007/s12016-021-08875-0] [PMID: 34264448]
[11]
Neale H, Garza-Mayers AC, Tam I, Yu J. Pediatric allergic contact dermatitis. Part I: Clinical features and common contact allergens in children. J Am Acad Dermatol 2021; 84(2): 235-44.
[http://dx.doi.org/10.1016/j.jaad.2020.11.002] [PMID: 33217510]
[12]
Tam I, Yu J. Pediatric contact dermatitis: What’s new. Curr Opin Pediatr 2020; 32(4): 524-30.
[http://dx.doi.org/10.1097/MOP.0000000000000919] [PMID: 32618793]
[13]
Dupuy E, Miller M, Harter N. What we have learned-milestones in pediatric contact dermatitis. Curr Dermatol Rep 2022; 11(1): 1-12.
[http://dx.doi.org/10.1007/s13671-022-00353-w] [PMID: 35369649]
[14]
Sharma V, Asati D. Pediatric contact dermatitis. Indian J Dermatol Venereol Leprol 2010; 76(5): 514-20.
[http://dx.doi.org/10.4103/0378-6323.69070] [PMID: 20826990]
[15]
Belloni Fortina A, Caroppo F, Tadiotto Cicogna G. Allergic contact dermatitis in children. Expert Rev Clin Immunol 2020; 16(6): 579-89.
[http://dx.doi.org/10.1080/1744666X.2020.1777858] [PMID: 32490693]
[16]
Murphy PB, Atwater AR, Mueller M. Allergic contact dermatitis. JAMA 2021; 157(3): 364.
[17]
Peiser M, Tralau T, Heidler J, et al. Allergic contact dermatitis: Epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Cell Mol Life Sci 2012; 69(5): 763-81.
[http://dx.doi.org/10.1007/s00018-011-0846-8] [PMID: 21997384]
[18]
Nguyen SH, Dang TP, MacPherson C, Maibach H, Maibach HI. Prevalence of patch test results from 1970 to 2002 in a multi-centre popu-lation in North America (NACDG). Contact Dermat 2008; 58(2): 101-6.
[http://dx.doi.org/10.1111/j.1600-0536.2007.01281.x] [PMID: 18186744]
[19]
Kohl L, Blondeel A, Song M. Allergic contact dermatitis from cosmetics. Retrospective analysis of 819 patch-tested patients. Dermatology 2002; 204(4): 334-7.
[http://dx.doi.org/10.1159/000063379] [PMID: 12077541]
[20]
Lunder T, Kansky A. Increase in contact allergy to fragrances: Patch-test results 1989-1998. Contact Dermat 2000; 43(2): 107-9.
[http://dx.doi.org/10.1034/j.1600-0536.2000.043002107.x] [PMID: 10945750]
[21]
Ljubojević Hadžavdić S, Pustišek N, Žužul K, Švigir A. Contact allergy: An update. Ital J Dermatol Venereol 2018; 153(3): 419-28.
[http://dx.doi.org/10.23736/S0392-0488.17.05844-8] [PMID: 29199804]
[22]
Warshaw EM, Shaver RL, DeKoven JG, et al. Patch test reactions associated with topical medications: A retrospective analysis of the North American Contact Dermatitis Group Data (2001-2018). Dermatitis 2022; 33(2): 144-54.
[http://dx.doi.org/10.1097/DER.0000000000000777] [PMID: 34405832]
[23]
Wennervaldt M, Ahlström MG, Menné T, et al. Chromium and cobalt release from metallic earrings from the Danish market. Contact Dermat 2021; 85(5): 523-30.
[http://dx.doi.org/10.1111/cod.13917] [PMID: 34148232]
[24]
Slodownik D, Rabah S, Levi A, et al. The relationship between atopy and allergic contact dermatitis in Israeli patients. Postepy Dermatol Alergol 2022; 39(1): 159-63.
[http://dx.doi.org/10.5114/ada.2022.113606] [PMID: 35369630]
[25]
Rodrigues DF, Marcos EMA. Patch-test results in children and adolescents: Systematic review of a 15-year period. An Bras Dermatol 2016; 91: 64-72.
[26]
Cai X, Smirnova L, Ma Z, Orlova E. Allergic contact dermatitis and associated allergic dermatoses: Epidemiological, allergic, and immunological characteristics. Postepy Dermatol Alergol 2021; 38(6): 1058-64.
[http://dx.doi.org/10.5114/ada.2021.104692] [PMID: 35126015]
[27]
Seine AJ, Baird EA, Chan L, et al. A baseline patch test series for New Zealand. Australas J Dermatol 2021; 62(4): 489-95.
[http://dx.doi.org/10.1111/ajd.13673] [PMID: 34293187]
[28]
Lee EY, Wee CLP, Tan CH, et al. Pediatric patch testing in a multi‐ethnic Asian population: A retrospective review. Pediatr Dermatol 2022; 39(1): 69-76.
[http://dx.doi.org/10.1111/pde.14904] [PMID: 34971009]
[29]
Jacob SE, Herro EM, Sullivan SE, Matiz C, Eichenfield L, Hamann C. Safety and efficacy evaluation of TRUE TEST panels 1.1, 2.1, and 3.1 in children and adolescents. Dermatitis 2011; 22(4): 204-10.
[30]
Kundak S. Patch test results of contact sensitization in children without atopic dermatitis: A single tertiary center experience. Dermatitis 2020; 31(2): 153-6.
[http://dx.doi.org/10.1097/DER.0000000000000530] [PMID: 31609858]
[31]
Yılmaz Z, Özkaya E. Patch test results in terms of the recently recommended allergens in children and adolescents: A retrospective cohort study over 22 years from Turkey. Contact Dermat 2021; 85(2): 198-210.
[http://dx.doi.org/10.1111/cod.13842] [PMID: 33759232]
[32]
Lee PW, Elsaie ML, Jacob SE. Allergic contact dermatitis in children: Common allergens and treatment: A review. Curr Opin Pediatr 2009; 21(4): 491-8.
[http://dx.doi.org/10.1097/MOP.0b013e32832d2008] [PMID: 19584724]
[33]
Neale H, Garza-Mayers AC, Tam I, Yu J. Pediatric allergic contact dermatitis. Part 2: Patch testing series, procedure, and unique scenarios. J Am Acad Dermatol 2021; 84(2): 247-55.
[http://dx.doi.org/10.1016/j.jaad.2020.11.001] [PMID: 33217511]
[34]
Thyssen JP, Linneberg A, Menné T, Johansen JD. The epidemiology of contact allergy in the general population - prevalence and main findings. Contact Dermat 2007; 57(5): 287-99.
[http://dx.doi.org/10.1111/j.1600-0536.2007.01220.x] [PMID: 17937743]
[35]
Ng A, Atwater AR, Reeder M. Contact allergy to topical medicaments, Part 2: Steroids, immunomodulators, and anesthetics, Oh My! Cutis 2022; 109(1): 36-9.
[http://dx.doi.org/10.12788/cutis.0436] [PMID: 35180054]
[36]
Geier J, Ballmer-Weber B, Buhl T, et al. Is benzyl alcohol a significant contact sensitizer? J Eur Acad Dermatol Venereol 2022; 36(6): 866-72.
[http://dx.doi.org/10.1111/jdv.17968] [PMID: 35080274]
[37]
Nguyen HL, Yiannias JA. Contact dermatitis to medications and skin products. Clin Rev Allergy Immunol 2019; 56(1): 41-59.
[http://dx.doi.org/10.1007/s12016-018-8705-0] [PMID: 30145645]
[38]
Mortz CG, Lauritsen JM, Bindslev-Jensen C, Andersen KE. Contact allergy and allergic contact dermatitis in adolescents: Prevalence measures and associations. Acta Derm Venereol 2002; 82(5): 352-8.
[http://dx.doi.org/10.1080/000155502320624087] [PMID: 12430734]
[39]
Leonard A, Guttman-Yassky E. Unique molecular signatures of contact dermatitis and implications for treatment. Clin Rev Allergy Immunol 2019; 56(1): 1-8.
[http://dx.doi.org/10.1007/s12016-018-8685-0] [PMID: 29754191]
[40]
Dhingra N, Shemer A, Correa da Rosa J, et al. Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response. J Allergy Clin Immunol 2014; 134(2): 362-72.
[http://dx.doi.org/10.1016/j.jaci.2014.03.009] [PMID: 24768652]
[41]
White SI, Friedmann PS, Moss C, Simpson JM. The effect of altering area of application and dose per unit area on sensitization by DNCB. Br J Dermatol 1986; 115(6): 663-8.
[http://dx.doi.org/10.1111/j.1365-2133.1986.tb06646.x] [PMID: 3801307]
[42]
Iwasaki A. Local advantage: skin DCs prime; skin memory T cells protect. Nat Immunol 2009; 10(5): 451-3.
[http://dx.doi.org/10.1038/ni0509-451] [PMID: 19381136]
[43]
Luo Y, Zhu Z, Li B, et al. Keratin 17 Promotes T Cell Response in Allergic Contact Dermatitis by Upregulating C-C Motif Chemokine Ligand 20. Front Immunol 2022; 13764793
[http://dx.doi.org/10.3389/fimmu.2022.764793] [PMID: 35178048]
[44]
Czarnobilska E, Obtulowicz K, Dyga W, Wsolek-Wnek K, Spiewak R. Contact hypersensitivity and allergic contact dermatitis among school children and teenagers with eczema. Contact Dermat 2009; 60(5): 264-9.
[http://dx.doi.org/10.1111/j.1600-0536.2009.01537.x] [PMID: 19397618]
[45]
Belhadjali H, Mohamed M, Youssef M, Mandhouj S, Chakroun M, Zili J. Contact sensitization in atopic dermatitis: Results of a prospective study of 89 cases in Tunisia. Contact Dermat 2008; 58(3): 188-9.
[http://dx.doi.org/10.1111/j.1600-0536.2007.01248.x] [PMID: 18279174]
[46]
Thyssen JP, Linneberg A, Engkilde K, Menné T, Johansen JD. Contact sensitization to common haptens is associated with atopic dermatitis: New insight. Br J Dermatol 2012; 166(6): 1255-61.
[http://dx.doi.org/10.1111/j.1365-2133.2012.10852.x] [PMID: 22283138]
[47]
Malajian D, Belsito DV. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis. J Am Acad Dermatol 2013; 69(2): 232-7.
[http://dx.doi.org/10.1016/j.jaad.2013.03.012] [PMID: 23583066]
[48]
Hamann CR, Hamann D, Egeberg A, Johansen JD, Silverberg J, Thyssen JP. Association between atopic dermatitis and contact sensitization: A systematic review and meta-analysis. J Am Acad Dermatol 2017; 77(1): 70-8.
[http://dx.doi.org/10.1016/j.jaad.2017.02.001] [PMID: 28392290]
[49]
Chan CX, Zug KA. Diagnosis and Management of Dermatitis, Including Atopic, Contact, and Hand Eczemas. Med Clin North Am 2021; 105(4): 611-26.
[http://dx.doi.org/10.1016/j.mcna.2021.04.003] [PMID: 34059241]
[50]
Brown C, Yu J. Pediatric Allergic Contact Dermatitis. Immunol Allergy Clin North Am 2021; 41(3): 393-408.
[http://dx.doi.org/10.1016/j.iac.2021.04.004] [PMID: 34225896]
[51]
Schmidlin K, Sani S, Bernstein DI, Fonacier L. A hands-on approach to contact dermatitis and patch testing. J Allergy Clin Immunol Pract 2020; 8(6): 1883-93.
[http://dx.doi.org/10.1016/j.jaip.2020.02.009] [PMID: 32112924]
[52]
Fonacier L. A Practical Guide to Patch Testing. J Allergy Clin Immunol Pract 2015; 3(5): 669-75.
[http://dx.doi.org/10.1016/j.jaip.2015.05.001] [PMID: 26054552]
[53]
Fonacier L, Noor I. Contact dermatitis and patch testing for the allergist. Ann Allergy Asthma Immunol 2018; 120(6): 592-8.
[http://dx.doi.org/10.1016/j.anai.2018.03.003] [PMID: 29522811]
[54]
Garg V, Brod B, Gaspari AA. Patch testing: Uses, systems, risks/benefits, and its role in managing the patient with contact dermatitis. Clin Dermatol 2021; 39(4): 580-90.
[http://dx.doi.org/10.1016/j.clindermatol.2021.03.005] [PMID: 34809764]
[55]
Frings VG, Böer-Auer A, Breuer K. Histomorphology and immunophenotype of eczematous skin lesions revisited-skin biopsies are not reliable in differentiating allergic contact dermatitis, irritant contact dermatitis, and atopic dermatitis. Am J Dermatopathol 2018; 40(1): 7-16.
[http://dx.doi.org/10.1097/DAD.0000000000000842] [PMID: 28296664]
[56]
Kadyk DL, McCarter K, Achen F, Belsito DV. Quality of life in patients with allergic contact dermatitis. J Am Acad Dermatol 2003; 49(6): 1037-48.
[http://dx.doi.org/10.1016/S0190-9622(03)02112-1] [PMID: 14639382]
[57]
Hon KL, Chu S, Leung AKC. Quality of life for children with allergic skin diseases. Curr Pediatr Rev 2022; 18(3): 191-6.
[http://dx.doi.org/10.2174/1573396317666210901124211] [PMID: 34488587]
[58]
Kiebert G, Sorensen SV, Revicki D, et al. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol 2002; 41(3): 151-8.
[http://dx.doi.org/10.1046/j.1365-4362.2002.01436.x] [PMID: 12010340]
[59]
Chren MM. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin 2012; 30(2) 231-236, xiii.
[http://dx.doi.org/10.1016/j.det.2011.11.003] [PMID: 22284137]
[60]
Kadyk DL, Hall S, Belsito DV. Quality of life of patients with allergic contact dermatitis: An exploratory analysis by gender, ethnicity, age, and occupation. Dermatitis 2004; 15(3): 117-24.
[http://dx.doi.org/10.2310/6620.2004.04007] [PMID: 15724345]
[61]
Botto N, Raffi J, Trivedi M, Ramirez F, Allen IE, Chren MM. Validating a Quality-of-Life Instrument for Allergic Contact Dermatitis. Dermatitis 2019; 30(5): 300-5.
[http://dx.doi.org/10.1097/DER.0000000000000515] [PMID: 31524758]
[62]
Raffi J, Elaine Allen I, Botto N. Validating Responsiveness of a Quality-of-Life Instrument for Allergic Contact Dermatitis. Dermatitis 2020; 31(3): 209-14.
[http://dx.doi.org/10.1097/DER.0000000000000542] [PMID: 32049717]
[63]
Hon KL, Ng WGG, Kung JSC, Cheng NS, Ng DKK, Leung TF. Utility of the Pediatric Allergic Disease Quality of Life Questionnaire for childhood eczema. Br J Dermatol 2019; 181(2): 290-5.
[http://dx.doi.org/10.1111/bjd.17710] [PMID: 30706447]
[64]
Nicholson PJ, Llewellyn D, English JS. Evidence-based guidelines for the prevention, identification and management of occupational contact dermatitis and urticaria. Contact Dermat 2010; 63(4): 177-86.
[http://dx.doi.org/10.1111/j.1600-0536.2010.01763.x] [PMID: 20831687]
[65]
Adisesh A, Robinson E, Nicholson PJ, Sen D, Wilkinson M. U.K. standards of care for occupational contact dermatitis and occupational contact urticaria. Br J Dermatol 2013; 168(6): 1167-75.
[http://dx.doi.org/10.1111/bjd.12256] [PMID: 23374107]
[66]
Hon KL, Chu S, Leung AKC, Wong A. Atopic dermatitis: Conventional and integrative medicine. Curr Pediatr Rev 2022; 18(2): 84-96.
[http://dx.doi.org/10.2174/1573396317666210716152325] [PMID: 34279204]
[67]
Hon KL, Leung AKC, Leung TNH, Lee VWY. Investigational drugs for atopic dermatitis. Expert Opin Investig Drugs 2018; 27(8): 637-47.
[http://dx.doi.org/10.1080/13543784.2018.1494723] [PMID: 30058384]
[68]
Bhatia J, Sarin A, Wollina U, et al. Review of biologics in allergic contact dermatitis. Contact Dermat 2020; 83(3): 179-81.
[http://dx.doi.org/10.1111/cod.13584] [PMID: 32347968]
[69]
Hogan DJ, Dannaker CJ, Maibach HI. The prognosis of contact dermatitis. J Am Acad Dermatol 1990; 23(2): 300-7.
[http://dx.doi.org/10.1016/0190-9622(90)70213-2] [PMID: 2145326]
[70]
Hogan DJ, Dannaker CJ, Maibach HI, Lal S. An international survey on the prognosis of occupational contact dermatitis of the hands. Derm Beruf Umwelt 1990; 38(5): 143-7.
[71]
Ibanez MA, Levoska MA, Zheng DX, Nedorost ST. Sodium metabisulfite allergic contact dermatitis from lidocaine exposure in an operating room nurse. Dermatitis 2021; 32(6): e108-9.
[http://dx.doi.org/10.1097/DER.0000000000000710] [PMID: 34807534]
[72]
Tan MG, Li HO, Pratt MD. Systemic allergic dermatitis to sodium metabisulfite in local anesthetic solution. Contact Dermat 2022; 86(2): 120-1.
[http://dx.doi.org/10.1111/cod.13978] [PMID: 34549447]
[73]
Hansel K, Sensini C, Caposciutti P, et al. Systemic allergic dermatitis during tetracaine hydrochloride patch testing. Contact Dermat 2021; 85(5): 596-8.
[http://dx.doi.org/10.1111/cod.13921] [PMID: 34180549]
[74]
Pereira TM, Flour M, Goossens A. Allergic contact dermatitis from modified colophonium in wound dressings. Contact Dermat 2007; 56(1): 5-9.
[http://dx.doi.org/10.1111/j.1600-0536.2007.01026.x] [PMID: 17177702]
[75]
Traidl S, Werfel T, Ruëff F, Simon D, Lang C, Geier J. Patch test results in patients with suspected contact allergy to shoes: Retrospective IVDK data analysis 2009-2018. Contact Dermat 2021; 85(3): 297-306.
[http://dx.doi.org/10.1111/cod.13868] [PMID: 33882155]
[76]
Lahouel I, Thabouti M, Belhadjali H, et al. Pustular allergic contact dermatitis caused by colophonium in depilatory wax. Contact Dermat 2021; 84(2): 130-2.
[http://dx.doi.org/10.1111/cod.13695] [PMID: 32876340]
[77]
Tous-Romero F, Vico-Alonso C, Pinilla-Martín B, Ortiz de Frutos J. Allergic contact dermatitis from a depilatory wax. Contact Dermat 2020; 83(1): 65.
[http://dx.doi.org/10.1111/cod.13530]
[78]
Batchelor JM, Todd PM. Music and matrimony - hazards for the colophonium allergic patient. J R Soc Med 2010; 103(8): 332-4.
[http://dx.doi.org/10.1258/jrsm.2010.090418] [PMID: 20610620]
[79]
Tan S, Tam MM, Nixon RL. Allergic contact dermatitis to Myroxylon pereirae (Balsam of Peru) in papaw ointment causing cheilitis. Australas J Dermatol 2011; 52(3): 222-3.
[http://dx.doi.org/10.1111/j.1440-0960.2011.00772.x] [PMID: 21834822]
[80]
de Groot AC. Myroxylon pereirae resin (balsam of Peru) - A critical review of the literature and assessment of the significance of positive patch test reactions and the usefulness of restrictive diets. Contact Dermat 2019; 80(6): 335-53.
[http://dx.doi.org/10.1111/cod.13263]
[81]
Turić P, Lipozencić J, Milavec-Puretić V, Kulisić SM. Contact allergy caused by fragrance mix and Myroxylon pereirae (balsam of Peru)--a retrospective study. Coll Antropol 2011; 35(1): 83-7.
[82]
Guarneri F, Costa C, Cannavò SP, et al. Release of nickel and chromium in common foods during cooking in 18/10 (grade 316) stainless steel pots. Contact Dermat 2017; 76(1): 40-8.
[http://dx.doi.org/10.1111/cod.12692] [PMID: 27804135]
[83]
Rodríguez-Jiménez P, Descalzo MA, Giménez Arnau AM, et al. Trend of relevant contact allergens of the feet in Spain over a period of 10 years. Contact Dermat 2020; 82(4): 211-7.
[http://dx.doi.org/10.1111/cod.13419] [PMID: 31625171]
[84]
Admani S, Jacob SE. Allergic contact dermatitis in children: Review of the past decade. Curr Allergy Asthma Rep 2014; 14(4): 421.
[http://dx.doi.org/10.1007/s11882-014-0421-0] [PMID: 24504525]
[85]
Goossens A, Aerts O. Contact allergy to and allergic contact dermatitis from formaldehyde and formaldehyde releasers: A clinical review and update. Contact Dermat 2022; 87(1): 20-7.
[http://dx.doi.org/10.1111/cod.14089] [PMID: 35229319]
[86]
Reeder MJ. Allergic contact dermatitis to fragrances. Dermatol Clin 2020; 38(3): 371-7.
[http://dx.doi.org/10.1016/j.det.2020.02.009] [PMID: 32475515]
[87]
Silverberg NB, Pelletier JL, Jacob SE, et al. Nickel allergic contact dermatitis: Identification, treatment, and prevention. Pediatrics 2020; 145(5)e20200628
[http://dx.doi.org/10.1542/peds.2020-0628] [PMID: 32341178]
[88]
Hayakawa M, Suzuki C, Zhu Y, Anzai H. Allergic contact dermatitis to gold in the parts of in‐ear headphones. Contact Dermat 2022; 86(4): 328-30.
[http://dx.doi.org/10.1111/cod.14036] [PMID: 34978717]
[89]
Soriano LF, Chowdhury MMU, Cooper SM, et al. Current prevalence and relevance of positive patch test reactions to cosmetic and non-cosmetic isothiazolinones in the UK. Br J Dermatol 2021; 185(1): 223-5.
[http://dx.doi.org/10.1111/bjd.19898] [PMID: 33657657]
[90]
Ito A, Suzuki K, Matsunaga K, et al. Patch testing with the J apanese baseline series 2015: A 4‐year experience. Contact Dermat 2022; 86(3): 189-95.
[http://dx.doi.org/10.1111/cod.14027] [PMID: 34921568]
[91]
Mahajan V, Mehta K, Chauhan P, et al. Clinical, occupational and allergological profile of 455 patients with occupational contact dermatitis: A 5-year study from a tertiary care center of North India. Indian Dermatol Online J 2021; 12(4): 541-8.
[http://dx.doi.org/10.4103/idoj.IDOJ_768_20] [PMID: 34430457]
[92]
Kamerud KL, Hobbie KA, Anderson KA. Stainless steel leaches nickel and chromium into foods during cooking. J Agric Food Chem 2013; 61(39): 9495-501.
[http://dx.doi.org/10.1021/jf402400v] [PMID: 23984718]
[93]
Jacob SE, Goldenberg A, Pelletier JL, Fonacier LS, Usatine R, Silverberg N. Nickel allergy and our children’s health: A review of indexed cases and a view of future prevention. Pediatr Dermatol 2015; 32(6): 779-85.
[http://dx.doi.org/10.1111/pde.12639] [PMID: 26212605]
[94]
Draelos ZD. A clinical evaluation of a permanent hair dye designed to reduce allergic contact dermatitis and hair damage. J Cosmet Dermatol 2022; 21(9): 3925-8.
[http://dx.doi.org/10.1111/jocd.15212] [PMID: 35790071]
[95]
Encabo Durán B, Romero-Pérez D, Silvestre Salvador JF. Allergic contact dermatitis due to Paraphenylenediamine: An update. Actas Dermo-Sifiliográficas 2018; 109(7): 602-9.
[http://dx.doi.org/10.1016/j.adengl.2018.06.017] [PMID: 29496197]
[96]
Schubert S, Lessmann H, Schnuch A, Uter W, Geier J. Factors associated with p -phenylenediamine sensitization: Data from the Information Network of Departments of Dermatology, 2008-2013. Contact Dermat 2018; 78(3): 199-207.
[http://dx.doi.org/10.1111/cod.12920] [PMID: 29322532]
[97]
Veverka KK, Hall MR, Yiannias JA, et al. Trends in patch testing with the mayo clinic standard series, 2011-2015. Dermatitis 2018; 29(6): 310-5.
[http://dx.doi.org/10.1097/DER.0000000000000411] [PMID: 30422883]
[98]
Boffa MJ, Beck MH. Allergic contact dermatitis from quaternium 15 in Oilatum cream. Contact Dermat 1996; 35(1): 45-6.
[http://dx.doi.org/10.1111/j.1600-0536.1996.tb02265.x] [PMID: 8896954]
[99]
Tosti A, Maria Piraccini B, Bardazzo F. Occupational contact dermatitis due to quaternium 15. Contact Dermat 1990; 23(1): 41-2.
[http://dx.doi.org/10.1111/j.1600-0536.1990.tb00082.x] [PMID: 2144806]
[100]
Oborina RI, Kratasiuk VA. A biotest for determining human skin contamination by platinoids. Gig Tr Prof Zabol 1989; 12: 42-4.
[101]
Roshchin AV, Veselov VG, Panova AI. Industrial toxicology of metals of the platinum group. J Hyg Epidemiol Microbiol Immunol 1984; 28(1): 17-24.
[PMID: 6715873]
[102]
Cristaudo A, Sera F, Severino V, De Rocco M, Di Lella E, Picardo M. Occupational hypersensitivity to metal salts, including platinum, in the secondary industry. Allergy 2005; 60(2): 159-64.
[http://dx.doi.org/10.1111/j.1398-9995.2004.00521.x] [PMID: 15647035]
[103]
Jiang Y, Wang S, Lyu J, Li J, Diao Q. Contact dermatitis associated with a cosmetic cream. J Cosmet Dermatol 2022; 21(10): 4479-81.
[http://dx.doi.org/10.1111/jocd.14847] [PMID: 35156746]
[104]
Zhang AJ, Aschenbeck KA, Law BF. B’Hymer C, Siegel PD, Hylwa SA. Urushiol compounds detected in toxicodendron-labeled consumer products using mass spectrometry. Dermatitis 2020; 31(2): 134-9.
[http://dx.doi.org/10.1097/DER.0000000000000544] [PMID: 32168145]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy